Chronic autoimmune care is uncoordinated, wasteful and often not evidence-based resulting in over $18 billion wasted spend and poor patient outcomes. Payers increasingly expecting life sciences to prove value in contracting for specialty Rx market access.
CrossBridge has reimagined Chronic Autoimmune Care. A SaaS specialty care platform is designed to put autoimmune patients first, improve outcomes, and lower the cost of care. We work with payers, providers and life science to collaborate in a value-based setting.